BioCentury
ARTICLE | Financial News

Nimbus raises $43M series B round

March 19, 2015 2:04 AM UTC

Nimbus Therapeutics LLC (Cambridge, Mass.) raised $43 million in a series B round led by Pfizer Venture Investments and Lightstone Ventures. Existing investors Atlas Venture, SR One, Lilly Ventures and Bill Gates also participated. Pfizer Venture Investments' Elaine Jones and Lightstone's Chris Christoffersen will join Nimbus' board. ...